Cartesian Therapeutics Inc — Financial Statements (NASDAQ:RNAC) | MetaTrader

Open full chart

Haberler

Cartesian Therapeutics, Inc. (RNAC) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript

Cartesian Therapeutics yönetim kurulu üyesi Murat Kalayoğlu 31 Mart’ta istifa edecek

BTIG, Cartesian Therapeutics için Al tavsiyesini yineledi

BTIG reiterates Buy on Cartesian Therapeutics stock, $44 target

Mizuho, Cartesian Therapeutics hissesi için tavsiyesini korudu

Mizuho reiterates Cartesian Therapeutics stock rating on trial progress

Kyverna Stock: The King Of The CAR-T Autoimmune Revolution (NASDAQ:KYTX)

Cartesian Therapeutics, Inc. (RNAC) Upgraded to Buy: What Does It Mean for the Stock?

Johnson & Johnson Touts Positive Results For Lupus Treatment - Johnson & Johnson (NYSE:JNJ)

2026 Market Outlook: Focus On Pharma For Consistent Returns, Potential Skyrocketing Shares

H.C. Wainwright, Cartesian Therapeutics hisse senedi fiyat hedefini 40 dolardan 30 dolara düşürdü

H.C. Wainwright lowers Cartesian Therapeutics stock price target to $30 from $40